Celltrion signs manufacturing agreement with Bristol-Myers Squibb Company

Published: 2006-08-02 06:58:00

Updated: 2006-08-02 06:58:00

Celltrion announced on July 31 that it has completed an agreement with Bristol-Myers Squibb Company to manufacture biologic products being developed by Bristol-Myers Squibb.

In the bio-complex, Celltrion will initiate an expansion to build an additional 150,000-liter production bioreactor and ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK